RXR/RAR receptor modulators claimed by CIRD Galderma for skin and other disorders Sep. 9, 1998 No Comments
Biotech Australia announces encouraging early clinical trial results with leg ulcer treatment Sep. 4, 1998 No Comments
Access signs licensing agreement with Paladin to market amlexanox in Canada Aug. 27, 1998 No Comments
RSS